PureTech Health plc (PTCHF)
OTCMKTS · Delayed Price · Currency is USD
1.698
-0.152 (-8.22%)
At close: Feb 10, 2026

PureTech Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
3994506728941,1381,561
Market Cap Growth
-9.41%-33.05%-24.82%-21.39%-27.10%29.08%
Enterprise Value
228884465727761,207
Last Close Price
1.702.002.383.073.975.48
PE Ratio
7.888.41---260.81
PS Ratio
62.5093.25201.9457.2765.44132.65
PB Ratio
1.081.101.471.631.952.39
P/TBV Ratio
1.061.091.451.651.922.33
EV/Sales Ratio
36.2918.29133.9236.6044.65102.60
Debt / Equity Ratio
0.440.410.300.090.090.12
Net Debt / Equity Ratio
-0.45-0.52-0.42-0.55-0.71-0.50
Net Debt / EBITDA Ratio
1.451.591.351.582.832.83
Net Debt / FCF Ratio
1.671.591.811.682.522.39
Asset Turnover
0.010.010.010.020.020.01
Quick Ratio
8.359.196.643.842.102.25
Current Ratio
8.499.336.763.992.222.29
Return on Equity (ROE)
9.44%6.42%-13.25%-6.55%-10.13%0.70%
Return on Assets (ROA)
-12.95%-13.10%-12.97%-15.00%-9.70%-7.74%
Return on Invested Capital (ROIC)
-53.21%-58.89%-56.73%-95.20%-60.42%-6.74%
Return on Capital Employed (ROCE)
-22.90%-24.20%-22.60%-32.70%-20.90%-14.80%
Earnings Yield
12.69%11.89%-9.77%-5.63%-5.32%0.38%
FCF Yield
-25.11%-29.85%-15.76%-20.23%-14.40%-8.78%
Buyback Yield / Dilution
11.33%7.34%2.97%0.64%2.14%-0.37%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.